Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP7B is a copper-transporting ATPase, also known as ATPase copper-transporting beta. It is a P-type cation transport ATPase and a transporter essential for copper homeostasis. Its primary biological functions include the export of hepatic copper into bile and the transfer of copper to ceruloplasmin, a copper-carrying protein. Dysfunction or mutations in ATP7B are the primary cause of Wilson disease, leading to intracellular copper accumulation in the liver and brain. It is also associated with Wolff syndrome. Therapeutically, D-penicillamine (DPA) and zinc acetate are used to manage Wilson disease by interacting with copper metabolism, though their direct mechanism of action on ATP7B is indirect. Key structural features of ATP7B include six metal-binding domains, transmembrane domains with eight membrane-spanning helices, an actuator domain, a phosphorylation domain, and a nucleotide-binding domain.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATPase copper-transporting beta (ATP7B).